OBJECTIVE: Interaction of genotype and environment results in a specific phenotype of the clinical course of asthma. TGFβ-1 gene belongs to the important group of genes involved in the regulation of proliferation, differentiation, adhesion, and migration of a variety of cell types. TGFβ-1 is inhibitory for B and T cells, as well as IgE production. In particular, it is engaged in inflammation of the bronchi and airway remodeling in asthma, which processes are critical in the pathogenesis of the disease. The aim of this study was to evaluate the correlation between the level of expression of TGFβ-1 and the severity of asthma. METHODS: The study included 39 participants (20 healthy subjects and 19 patients with asthma). Each sample was analysed by using real time PCR. RESULTS: There was statistical associations between the control group and the group of patients (p = 0,00007). It was demonstrated strong correlation between healthy and patients with severe asthma according GINA guidelines (p = 0,017). It was found the strong statistical correlation between healthy and patients with severe corticosteroid dependent asthma (p = 0,013). Correlations were observed between levels of asthma severity according to the ATS guidelines and controls. The influence of the level of TGFβ-1 mRNA expression and the severity of asthma (ATS) in the FEV1 (%) parameter value was found. CONCLUSION: It was found that an important role is played by TGFβ-1 in the pathogenesis of asthma.
OBJECTIVE: Interaction of genotype and environment results in a specific phenotype of the clinical course of asthma. TGFβ-1 gene belongs to the important group of genes involved in the regulation of proliferation, differentiation, adhesion, and migration of a variety of cell types. TGFβ-1 is inhibitory for B and T cells, as well as IgE production. In particular, it is engaged in inflammation of the bronchi and airway remodeling in asthma, which processes are critical in the pathogenesis of the disease. The aim of this study was to evaluate the correlation between the level of expression of TGFβ-1 and the severity of asthma. METHODS: The study included 39 participants (20 healthy subjects and 19 patients with asthma). Each sample was analysed by using real time PCR. RESULTS: There was statistical associations between the control group and the group of patients (p = 0,00007). It was demonstrated strong correlation between healthy and patients with severe asthma according GINA guidelines (p = 0,017). It was found the strong statistical correlation between healthy and patients with severe corticosteroid dependent asthma (p = 0,013). Correlations were observed between levels of asthma severity according to the ATS guidelines and controls. The influence of the level of TGFβ-1 mRNA expression and the severity of asthma (ATS) in the FEV1 (%) parameter value was found. CONCLUSION: It was found that an important role is played by TGFβ-1 in the pathogenesis of asthma.
Authors: I Ohno; Y Nitta; K Yamauchi; H Hoshi; M Honma; K Woolley; P O'Byrne; G Tamura; M Jordana; K Shirato Journal: Am J Respir Cell Mol Biol Date: 1996-09 Impact factor: 6.914
Authors: Y Suzuki; T Tanigaki; D Heimer; W Wang; W G Ross; G A Murphy; A Sakai; H H Sussman; T H Vu; T A Raffin Journal: J Appl Physiol (1985) Date: 1994-09
Authors: Michał Panek; Tadeusz Pietras; Artur Fabijan; Jan Zioło; Łukasz Wieteska; Beata Małachowska; Wojciech Fendler; Janusz Szemraj; Piotr Kuna Journal: Inflammation Date: 2015-08 Impact factor: 4.092
Authors: Michał Panek; Mateusz Jonakowski; Jan Zioło; Tadeusz Pietras; Łukasz Wieteska; Beata Małachowska; Łukasz Mokros; Janusz Szemraj; Piotr Kuna Journal: Mol Neurobiol Date: 2016-02-13 Impact factor: 5.590
Authors: Mateusz Jonakowski; Jan Zioło; Marcelina Koćwin; Marcelina Przemęcka; Łukasz Mokros; Michał Panek; Janusz Szemraj; Piotr Kuna Journal: Exp Ther Med Date: 2017-09-05 Impact factor: 2.447
Authors: Michał Panek; Tadeusz Pietras; Artur Fabijan; Jan Zioło; Lukasz Wieteska; Beata Małachowska; Wojciech Fendler; Janusz Szemraj; Piotr Kuna Journal: Int J Mol Med Date: 2014-08-11 Impact factor: 4.101
Authors: Michał Gabriel Panek; Michał Seweryn Karbownik; Karol Maksymilian Górski; Marcelina Koćwin; Grzegorz Kardas; Mateusz Marynowski; Piotr Kuna Journal: Clin Transl Allergy Date: 2022-07-02 Impact factor: 5.657